Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Britt

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of General Internal Medicine|November 8, 2013
Complementary medicineRahul S Vedula, Gregory Britt, Richard I Kopelman, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Treatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical OutcomesLeah Wells, Michael Cerniglia, Sarah Hall, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of General Internal Medicine|November 8, 2013
Complementary medicineRahul S Vedula, Gregory Britt, Richard I Kopelman, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Treatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical OutcomesLeah Wells, Michael Cerniglia, Sarah Hall, et al.
Pageof 1